ArticleFrontiers in pharmacology2025

Synergistic therapy for diabetic retinopathy via dual blockade of VEGF-A and TNF-α with a bispecific nanobody.

Chenlu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.